GQG Partners LLC Buys 341,812 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

GQG Partners LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 42.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,145,300 shares of the medical equipment provider's stock after acquiring an additional 341,812 shares during the period. GQG Partners LLC owned 0.32% of Intuitive Surgical worth $597,801,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the 4th quarter valued at approximately $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical during the fourth quarter valued at $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical in the fourth quarter worth $31,000. Finally, Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth $36,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Down 3.2 %

NASDAQ:ISRG traded down $16.06 during mid-day trading on Friday, hitting $491.84. 1,966,546 shares of the company traded hands, compared to its average volume of 1,527,047. The stock's fifty day moving average price is $556.28 and its 200-day moving average price is $532.68. The firm has a market cap of $175.18 billion, a price-to-earnings ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Remove Ads

Insider Buying and Selling

In other news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the subject of several recent analyst reports. UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Truist Financial reduced their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a research report on Monday, March 17th. Evercore ISI upped their price objective on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, CICC Research initiated coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 target price for the company. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.